Christiansen, S. N. Et Al. 2022. European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response. RHEUMATOLOGY , vol.61, no.9 , 3799-3807.

Christiansen, S. N., Ornbjerg, L. M., Rasmussen, S. H., Loft, A. G., Askling, J., Iannone, F., ... Zavada, J.(2022). European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response. RHEUMATOLOGY , vol.61, no.9, 3799-3807.

Christiansen, Sara Et Al. "European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response," RHEUMATOLOGY , vol.61, no.9, 3799-3807, 2022

Christiansen, Sara N. Et Al. "European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response." RHEUMATOLOGY , vol.61, no.9, pp.3799-3807, 2022

Christiansen, S. N. Et Al. (2022) . "European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response." RHEUMATOLOGY , vol.61, no.9, pp.3799-3807.

@article{article, author={Sara Nysom Christiansen Et Al. }, title={European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response}, journal={RHEUMATOLOGY}, year=2022, pages={3799-3807} }